Literature DB >> 9292738

Fine-needle aspiration cytopathology of malignant fibrous histiocytoma.

M D Berardo1, C N Powers, P E Wakely, M O Almeida, W J Frable.   

Abstract

BACKGROUND: Most pathologists generally accept malignant fibrous histiocytoma (MFH) as the most common soft tissue sarcoma in adults. This study examines the authors' aspiration cytopathology experience with this tumor, describes its cytomorphology, and determines the reliability of such a diagnosis by fine-needle aspiration biopsy (FNAB).
METHODS: The authors' files were reviewed for cases diagnosed as MFH by FNAB, and for surgical pathology cases of MFH previously aspirated but not diagnosed as such by cytology.
RESULTS: Fifty-two cases of MFH (by FNAB or histology) were recovered from the combined files; 42 aspirates had tissue confirmation. Patient age ranged from 15-88 years (mean, 63 years); the male:female ratio was 1.2. Thirty aspirates were from primary tumors, and 12 were from recurrences or metastases. From the 29 aspirates diagnosed as MFH, 24 (83%) were determined to be MFH on subsequent surgical excision. Four of the remaining cases were other sarcoma subtypes, and there was one organizing thrombus (false-positive). The remaining 13 aspirates were identified as unqualified sarcoma (11 cases) or a different sarcoma subtype (2 cases). Eleven of these were histologically diagnosed as MFH, and 2 as other sarcomas. No single cytologic feature or combination of features distinguished MFH. Patterns ranged from single cells to large storiform fragments. Spindled, plasmacytoid, and pleomorphic cell shapes were found; pleomorphic cells were often multinucleated. All cases of MFH had malignant nuclear morphology. Diagnostic pitfalls included low cellularity, obscuring blood and inflammation, and inadequate clinical and/or radiologic information.
CONCLUSIONS: The diagnostic role of FNAB in soft tissue lesions remains controversial. FNAB is important in the initial triage of patients with soft tissue tumors, and is particularly accurate for confirming recurrent or metastatic disease. Although making an initial diagnosis of sarcoma by FNAB is reliable, specific subtyping of them as MFH is more problematic.

Entities:  

Mesh:

Year:  1997        PMID: 9292738

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Fine-needle aspiration cytology of metaplastic carcinoma of the breast.

Authors:  Philip C W Lui; Gary M K Tse; Puay Hoon Tan; Gita Jayaram; Thomas C Putti; Benjaporn Chaiwun; Norman H L Chan; Patrick P L Lau; Kong Ling Mak; Aye T Khin
Journal:  J Clin Pathol       Date:  2006-06-23       Impact factor: 3.411

2.  Assessment of cyclin D1 overexpression as a prognostic factor in soft tissue sarcomas: role of laparoscopy and core needle biopsy.

Authors:  M Musella; F Fazioli; S Lombardi; C I Servodio; C De Martino; V Iacono; F Cigala; R Jovino
Journal:  Surg Endosc       Date:  2005-05-12       Impact factor: 4.584

3.  Management of spermatic cord tumors: a rare urologic malignancy.

Authors:  Dayron Rodríguez; Aria F Olumi
Journal:  Ther Adv Urol       Date:  2012-12

4.  Management of leiomyosarcomas of the spermatic cord: the role of reconstructive surgery.

Authors:  Stuart Enoch; Simon M Wharton; Douglas S Murray
Journal:  World J Surg Oncol       Date:  2005-04-28       Impact factor: 2.754

5.  Fine needle Aspiration Biopsy (FNAB) in the initial evaluation and diagnosis of palpable soft tissue lesions and with histologic correlation.

Authors:  Gabriel Olabiyi Ogun
Journal:  Pan Afr Med J       Date:  2015-01-15

6.  Scope of FNAC in the diagnosis of soft tissue tumors--a study from a tertiary cancer referral center in India.

Authors:  Bharat Rekhi; Biru D Gorad; Anagha C Kakade; Rf Chinoy
Journal:  Cytojournal       Date:  2007-10-31       Impact factor: 2.091

7.  Fine-needle aspiration cytology of soft tissue sarcoma: benefits and limitations.

Authors:  M Akerman
Journal:  Sarcoma       Date:  1998
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.